
EYPT Technical Analysis Summary (NASDAQ)
Analyze EYPT on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerEYPT Technical Analysis Summary (NASDAQ)
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) stock currently shows a bearish trend on the NASDAQ, supported by momentum and weak buying pressure.
Technical conditions suggest EyePoint Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that EyePoint Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 29.64
Stochastic %K: 16.00
Williams %R: -87.14
Rate of Change (ROC): -57.00
Takeaway:EyePoint Pharmaceuticals, Inc. shows oversold momentum, with rebound potential building.
MACD: -1.82
ADX: 24.04
ATR (14): 1.42
CCI (14): -95.21
Takeaway:EyePoint Pharmaceuticals, Inc. shows weakening trend signals, with bearish pressure building.
Takeaway:EyePoint Pharmaceuticals, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:EyePoint Pharmaceuticals, Inc. trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:EYPT shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:EyePoint Pharmaceuticals, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.